SCHEMBL24763944

SCHEMBL24763944

CCCC/N=C1\CCCCN1C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23806005 0.82 CYP2D6 (0.32) —
SCHEMBL21106891 0.82 CYP2D6 (0.32) —
SCHEMBL24673411 0.78 GBA1 (0.32) —
SCHEMBL21106883 0.77 LMNA (0.33) —
SCHEMBL21106632 0.77 LMNA (0.33) —
SCHEMBL25006291 0.72 — —
SCHEMBL23945120 0.72 — —
SCHEMBL11048329 0.72 INMT (0.34) —
SCHEMBL11048326 0.72 INMT (0.34) —
SCHEMBL21105704 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220356185-A1 MERTK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2022-11-10 — — US disclosed
Send feedback